The global distribution of
stromectol 3mg, featuring ivermectin, has been facilitated through partnerships between pharmaceutical companies, non-governmental organizations, and governmental agencies. These collaborative efforts aim to ensure equitable access to essential medications like ivermectin, particularly for vulnerable populations living in remote or resource-limited settings.
